Chair: We will consider scheduling recommendations by WHO and INCB. CND Secretariat: Recalls the substances and scheduling recommendations. Chair: Explains process to schedule substances under 1961, 1971 and 1988 conventions. Butonitazene WHO: Butonitazene, or butoxynitazene, is a benzimidazole-derived synthetic opioid not currently under international control and lacking recognized therapeutic use. It appears as a crystalline …
Russia
Item 4. Strategic management, budgetary and administrative questions
UNODC: Thank you Mr. Chair. Notable progress has been made. We have taken robust institutional steps. Programs have been consolidated to improve efficiency. New frameworks have been developed such as a new regional framework for the Arab states to guide the office in better supporting the member states. Program delivery reached $383.9 million, an increase …
CND Intersessional Meeting
Chair: First and foremost, I would like to welcome you to the first intersessional meeting of a CND during this ssession. To start, I want to ensure that we’re aligned on the significant matters we’ve encountered, particularly regarding the outcome document. First of all though, the floor is the Secretariat’s. Secretariat: Thank you, Mr. Chair. Good …
CND Reconvened 66th Session
Chair: Good Morning. The focus of our discussion pertains to Strategic Management budgetary and administrative motions in the context of our economy. Yesterday, in collaboration with the CCP CJ, we deliberated on the Consolidated budget for the biennium 2024-2025 for the United Nations Office on Drugs and Crime, referencing Containers document 5.2 (2013) and 15/2017, …
2023 CND & CCPCJ Reconvened Session
Secretariat: Distinguished delegates, ladies and gentlemen, As many of you are aware, the term of Her Excellency Ambassador (…), who served as the chair of the CCPCJ 32nd session, concluded at the onset of this conference. On 17 November, the Secretariat received a note from the chair of the African region nominating His Excellency, the Ambassador …
CND Tematic Discussion / Session 12 – Way Forward
Chair: I am grateful for your cooperation earlier this year. We had previously discussed the Resolution, outlining the review process, and collectively decided to convene before he regular committee session. The high-level segment is scheduled for March 14th and 15th, dedicated to assessing the implementation of international drug policy commitments. During this segment, we aim …